Tango Therapeutics share price logo

Tango Therapeutics

NASDAQ: TNGX

Mid Cap

$23.42

-4.51

(-16.15%)

Live

as on

Tango Therapeutics Stock Performance

as on October 24, 2026 at 6:26 am IST

  • Day's Low

    Day's High

    $22.68
    $25.94
    downward going graph

    3.16%

    Downside

    10.76%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.69
    $34.39
    downward going graph

    71.43%

    Downside

    46.84%

    Upside

    downward going graph

Tango Therapeutics share price movements today

Previous Close
$27.93
Open
$25.59
Volume
14.4M
Market Cap
$4.5B
Day's Low - High
$22.68 - $25.94
52 Week Low - High
$6.69 - $34.39

Tango Therapeutics Historical Returns

1 Month Return
+ 14.23 %
3 Month Return
+ 1.75 %
1 Year Return
+ 270.92 %
3 Year Return
+ 296.17 %
5 Year Return
+ 111.91 %

Tango Therapeutics Stock Fundamentals & Key Indicators

Check Tango Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.5B

EPS (TTM)

-0.85

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-31.74

Industry PE ratio

-10.60

PEG Ratio

-0.80

EBITDA

-121.9M

Revenue (TTM)

53.8M

Profit Margin

98.25%

Return On Equity TTM

-25.74%

Tango Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tango Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$4.5B111.91%-31.7498.25%0.00%
Neutral$98.1B-37.95%-30.80-12.57%0.00%
StrongBuy$44.0BNA27.4787.82%0.00%
StrongBuy$132.9B191.61%30.2886.04%0.00%
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Tango Therapeutics Stock including INR - Dollar returns

The Tango Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Tango Therapeutics investment value today

Current value as on today

₹3,36,396

Returns

₹2,36,396

(+236.4%)

Returns from Tango Therapeutics Stock

₹2,11,023 (+211.02%)

Dollar Impact

₹25,373 (+25.37%)

Analyst Recommendation on Tango Therapeutics Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for Tango Therapeutics. Average target price of $44.88

Tango Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Tango Therapeutics.

What analysts predicted

47.82%UPSIDE

Target Price

$44.88

Current Price

$23.42

Analyzed by

6 Analysts

High

$68

Target

$44.88

Low

$24

Tango Therapeutics target price $44.88, a slight upside of 47.82% compared to current price of $23.42. According to 6 analysts rating.

Indian Investors' Interest in Tango Therapeutics Stock

Search interest for Tango Therapeutics Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:24% versus previous 30 day period

Tango Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
6
19
11
4
5
3
53
-
-
-
Gross Profit
6
19
11
4
5
2
53
0
0
-
Operating Income
-42
-29
-32
-40
-42
-40
14
-41
-48
-59
EBITDA
-37
-24
-28
-37
-39
-38
16
-38
-45
-54
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-37
-25
-29
-37
-39
-38
15
-38
-45
-55
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-37
-25
-29
-37
-39
-38
15
-38
-45
-55
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
80.35%
100.00%
0.00%
0.00%
0.00%

Tango Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
24
7
37
24
36
42
62
Gross Profit
-7
6
37
24
36
42
60
Operating Income
-15
-52
-58
-111
-114
-145
-111
EBITDA
-14
-51
-57
-106
-99
-127
-99
Interest Expense
-
-
-
-
-
-
-
Depreciation
0
0
0
1
2
2
2
Income Before Tax
-14
-51
-57
-108
-101
-130
-101
Income Tax Expense
-
-
0
0
0
0
0
Net Income
-14
-51
-58
-108
-101
-130
-101
Net Profit Margin
-30.93%
78.77%
100.00%
100.00%
100.00%
100.00%
96.34%

Tango Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-37
-25
-29
-37
-39
-38
15
-38
-45
-55
Operating Cash Flow
-37
-23
-33
-36
-41
-36
-30
-29
-44
-38
Investing Cash Flow
-11
12
32
52
30
16
47
-135
9
-445
Financing Cash Flow
42
1
2
0
0
0
2
219
79
672
Change in Cash
-6
-9
1
16
-11
-19
19
53
45
187

Tango Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-14
-51
-58
-108
-101
-130
-101
Operating Cash Flow
-24
70
-59
-109
-117
-131
-138
Investing Cash Flow
0
-145
-183
26
41
86
-40
Financing Cash Flow
11
80
357
1
82
47
222
Change in Cash
25
5
114
-81
5
2
42

Global Institutional Holdings in Tango Therapeutics

Check out the Institutions with significant holdings in Tango Therapeutics.

Funds
Holdings
Andrew J.M. Spokes
7.28%
Vanguard
4.62%
iShares
3.95%
VANGUARD INDEX FUNDS
2.98%
SPDR
2.80%

Tango Therapeutics News & Key Events

  • img

    Today's Timeline - 23 October

    Fri, 04:10 PM

    -

    Tango Therapeutics reports promising Phase 1/2 data for vopimetostat in combination with RAS-ON inhibitors, showing an 82% objective response rate.

Insights on Tango Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TNGX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 3.18M → 53.81M (in $), with an average increase of 94.1% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, TNGX stock has moved up by 26.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 401.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 15.88M → -55.34M (in $), with an average decrease of 127.7% per quarter

About Tango Therapeutics

Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
OrganisationTango Therapeutics
Headquarters201 Brookline Avenue, Boston, MA, 02215, US
IndustryBiotechnology
CEOMalte Peters

Key Management of Tango Therapeutics

Name

Title

Dr. Antoni Ribas M.D., Ph.D.

Founder & Member of Scientific Advisory Board

Ms. Elizabeth Pingpank Hickin

VP of IR & Corporate Communications

Dr. Barbara L. Weber M.D.

Executive Officer

Prof. Alan Ashworth FRS, Ph.D.

Founder & Member of Scientific Advisory Board

Dr. William G. Kaelin Jr., M.D.

Founder & Member of Scientific Advisory Board

Mr. Jannik N. Andersen Ph.D.

Chief Scientific Officer

Ms. Julie Fogarty

Senior VP, General Counsel & Corporate Secretary

Dr. Malte Peters M.D.

President, CEO & Director

Dr. Adam S. Crystal M.D., Ph.D.

President of Research & Development

Mr. Matthew Gall M.B.A.

Chief Financial Officer

FAQs

What is Tango Therapeutics share price today?

Tango Therapeutics share price today is $23.42 as on . Tango Therapeutics share today touched a day high of $25.94 and a low of $22.68.

What is the 52 week high and 52 week low for Tango Therapeutics share?

Tango Therapeutics share touched a 52 week high of $34.39 on and a 52 week low of $6.69 on . Tango Therapeutics stock price today i.e. is trending at $23.42,which is 31.90% down from its 52 week high and 250.07% up from its 52 week low.

What is Tango Therapeutics's market capitalisation today?

Tango Therapeutics market capitalisation is $0.00T as on .

How to invest in Tango Therapeutics Stock (TNGX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tango Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Tango Therapeutics Stock (TNGX) from India?

Indian investors can start investing in Tango Therapeutics (TNGX) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Tango Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Tango Therapeutics share’s latest price of $23.42 as on October 24, 2026 at 12:56 am IST, you will get 0.4270 shares of Tango Therapeutics. Learn more about fractional shares .

What are the returns that Tango Therapeutics has given to Indian investors in the last 5 years?

Tango Therapeutics stock has given 111.91% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?